cephalosporin c has been researched along with cefclidin in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.86) | 18.7374 |
| 1990's | 23 (82.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katsu, K; Watanabe, NA | 1 |
| Sugiyama, I; Watanabe, N | 1 |
| Aoki, S; Ikezawa, Z; Miyata, M; Nishioka, K; Tone, T | 1 |
| Ikezawa, Z; Sugihara, Y; Ueno, J | 1 |
| Imada, A; Kita, Y; Yamazaki, T | 1 |
| Katsu, K; Watanabe, N | 1 |
| Hiruma, R; Katsu, K; Watanabe, N | 1 |
| Munakata, K; Satoh, M; Takeuchi, H; Yoshida, O | 2 |
| Akasaka, K; Furukawa, Y; Im, T; Inoue, K; Kageyama, T; Nasu, K; Ohyabu, H; Sannomiya, Y; Tatsumi, N; Yonezawa, T | 1 |
| Asakawa, N; Hata, K; Hiruma, R; Katsu, K; Toyosawa, T; Ueno, J; Watanabe, N; Yoshida, Y | 1 |
| Hibi, H; Horiba, M; Naide, Y; Suzuki, K | 1 |
| Komatsu, Y; Sugiyama, I; Yamauchi, H | 1 |
| Inoue, E; Iyobe, S; Katsu, K; Mitsuhashi, S; Watanabe, M | 1 |
| Iwahi, T; Nakao, M; Noji, Y; Yamazaki, T | 1 |
| Boice-Sowek, J; Dougherty, TJ; Kessler, RE; Pucci, MJ | 1 |
| Hiruma, R; Nishino, T; Obana, Y; Otsuki, M; Tashima, M | 1 |
| Barry, AL; Fuchs, PC; Jones, RN | 1 |
| Ashizawa, K; Hattori, T; Ishibashi, Y; Miyake, Y; Sato, T; Uchikawa, K | 2 |
| Akaniro, JC; Marks, MI; Stutman, HR; Vidaurre, CE | 1 |
| Inoue, E; Mitsuhashi, S | 1 |
| Kanamara, M; Morishita, N; Nakashima, M; Ohno, T; Okano, K; Setoyama, T; Tomono, Y; Uematsu, T; Ueno, K | 1 |
| Katsu, K; Kitoh, K; Moriyama, M; Watanabe, N | 1 |
| Chin, NX; Neu, HC; Novelli, A | 1 |
| Fukuhara, J; Kouda, M; Matsuzaki, H; Tamura, K; Udagawa, I | 1 |
| Algate, DR; Beard, DJ; Fujimoto, M; Jobling, CM; Kaneko, T; Katsu, K; Munt, PL; Yamauchi, H | 1 |
| Handa, T; Miyamoto, H; Murase, M; Saheki, S; Takeuchi, N | 1 |
2 trial(s) available for cephalosporin c and cefclidin
| Article | Year |
|---|---|
Enhancing effects of fluorescein on beta-lactam rash. I: High incidence of cefclidin rashes in an ophthalmological volunteer trial.
Topics: Adult; Cephalosporins; Double-Blind Method; Drug Eruptions; Fluoresceins; Humans; Hypersensitivity, Delayed; Incidence; Intraocular Pressure; Male | 1992 |
[Therapeutic effects of cefclidin against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cephalosporins; Child; Female; Humans; Immunocompromised Host; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Respiratory Tract Infections; Sepsis | 1992 |
26 other study(ies) available for cephalosporin c and cefclidin
| Article | Year |
|---|---|
Cefclidin (E1040), a novel cephalosporin: lack of selection of beta-lactamase overproducing mutants in an in vitro pharmacokinetic model system.
Topics: Bacteria; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enzyme Induction; Kinetics; Microbial Sensitivity Tests; Mutation | 1992 |
Role of the aminothiadiazolyl group in the antipseudomonal activity of cefclidin.
Topics: Bacterial Proteins; beta-Lactams; Carrier Proteins; Cephalosporinase; Cephalosporins; Enzyme Induction; Escherichia coli; Hexosyltransferases; Hydrolysis; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Structure-Activity Relationship; Thiadiazoles | 1992 |
Enhancing effects of fluorescein on beta-lactam rash. II: Enhancing effects of fluorescein on generalized rash induced by beta-lactam antibiotics in guinea pigs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Drug Eruptions; Drug Interactions; Fluoresceins; Guinea Pigs; Male | 1992 |
Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals.
Topics: Animals; Anti-Bacterial Agents; Biliary Tract; Blood Proteins; Cefozopran; Cefpirome; Ceftazidime; Cephalosporins; Dogs; Drug Administration Schedule; Female; Macaca fascicularis; Male; Mice; Mice, Inbred ICR; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Species Specificity | 1992 |
Bactericidal activity of cefclidin (E1040) against Pseudomonas aeruginosa under conditions simulating plasma pharmacokinetics: lack of development of chromosomally-mediated resistance to beta-lactams.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Humans; Imipenem; Membrane Proteins; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1992 |
Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
Topics: beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Isoelectric Focusing; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1992 |
Evaluation of the usefulness of a novel injectable cephalosporin, E1040, and ceftazidime for management of complicated urinary tract infections caused by Pseudomonas aeruginosa and Proteus mirabilis by using the rat urolithiasis model.
Topics: Animals; Ceftazidime; Cephalosporins; Drug Evaluation, Preclinical; Female; Injections, Intramuscular; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Urinary Calculi; Urinary Tract Infections | 1992 |
[Effect of cefclidin and E1077, new cephalosporins, on the alcohol-metabolizing system in rats].
Topics: Acetaldehyde; Aldehyde Dehydrogenase; Animals; Cephalosporins; Chromatography, High Pressure Liquid; Ethanol; Male; Mitochondria, Liver; Rats; Rats, Inbred Strains | 1992 |
[Clinical study of cefclidin on bacterial prostatitis].
Topics: Adult; Aged; Cephalosporins; Drug Evaluation; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prostatitis | 1992 |
Synthesis and structure-activity relationships of a new series of cephalosporins, E1040 and related compounds.
Topics: Bacteria; Cephalosporins; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Pseudomonas aeruginosa; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Infrared; Structure-Activity Relationship; Surface Properties | 1992 |
In vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1992 |
Antibacterial properties of SCE-2787, a new cephem antibiotic.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Cefozopran; Cefpirome; Ceftazidime; Cephalosporins; Escherichia coli; Hexosyltransferases; Microbial Sensitivity Tests; Microscopy; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus | 1992 |
Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.
Topics: Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefepime; Cefpirome; Cell Membrane; Cephalosporins; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa | 1991 |
In-vitro and in-vivo antibacterial activities of E1040, a new cephalosporin with potent antipseudomonal activity.
Topics: Animals; Bacteria; Cefmenoxime; Cefoperazone; Ceftazidime; Ceftizoxime; Cephalosporins; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Microscopy, Electron; Pseudomonas aeruginosa; Streptococcal Infections | 1990 |
In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.
Topics: Bacteria; Cefpirome; Ceftazidime; Cephalosporins; Culture Media; Microbial Sensitivity Tests | 1990 |
[Solid-state stability and preformulation study of a new parenteral cephalosporin antibiotics (E1040)].
Topics: Adjuvants, Pharmaceutic; Cephalosporins; Chemical Phenomena; Chemistry, Physical; Chlorine; Crystallization; Drug Design; Drug Stability; Freeze Drying; Halogens; Powders | 1990 |
In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.
Topics: Bacteria; Cephalosporins; Cystic Fibrosis; Kinetics; Microbial Sensitivity Tests; Sputum | 1990 |
Pseudopolymorphism and phase stability in four solid forms of (6R,7R)-7-[2-(5-amino-1,2,4-thiadiazol-3-yl)-(Z)-2-methoxy- iminoacetamid]-3- [(4-carbamoyl-1-quinuclidinio)methyl]-8-oxo-5-thia-1-azabicyclo - [4,2,0]oct-2-ene-2-carboxylate (E1040).
Topics: Adhesiveness; Cephalosporins; Chemical Phenomena; Chemistry; Crystallization; Drug Stability; Drug Storage; Freeze Drying; Humidity; Isomerism; Temperature; X-Ray Diffraction | 1989 |
Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391.
Topics: beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Citrobacter; Kinetics | 1989 |
Phase I study of E1040, a new parenteral cephem antibiotic.
Topics: Adult; Biological Assay; Cephalosporins; Chromatography, High Pressure Liquid; Drug Evaluation; Feces; Humans; Infusions, Intravenous; Male | 1989 |
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
Topics: Bacteria; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefazolin; Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Hexosyltransferases; Humans; Methicillin; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa | 1988 |
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.
Topics: Aminoglycosides; beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance; Drug Stability; Gentamicins; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1988 |
[Annual number of Pseudomonas aeruginosa isolated inpatients, and antibacterial activity of various antibiotics against P. aeruginosa isolated from clinical specimens of inpatients].
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Humans; Inpatients; Pseudomonas aeruginosa; Tobramycin | 1995 |
Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis.
Topics: Animals; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Female; Imipenem; Kidney Calculi; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Urinary Bladder Calculi; Urinary Calculi; Urinary Tract Infections | 1994 |
Pharmacological effects of cefclidin on the central nervous system.
Topics: Animals; Anticonvulsants; Body Temperature; Central Nervous System; Cephalosporins; Electroencephalography; Female; Injections, Intravenous; Male; Mice; Motor Activity; Rabbits; Rats; Rats, Wistar | 1993 |
[Activities of antipseudomonal agents against clinical isolates of Pseudomonas aeruginosa].
Topics: Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Pseudomonas aeruginosa; Serotyping; Sputum; Suppuration; Urine | 1995 |